Drug General Information (ID: DDI2WNPFI5)
  Drug Name Insulin human (zinc) Drug Info Diltiazem Drug Info
  Drug Type Hormones Small molecule
  Therapeutic Class Insulin/Antidiabetic Agents Antihypertensive Agents
  Structure

 Mechanism of Insulin human (zinc)-Diltiazem Interaction (Severity Level: Minor)
     Antagonize the effect of antidiabetic agents Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Insulin human (zinc) Diltiazem
      Mechanism Insulin Decrease the hypoglycemic effect of insulin
      Key Mechanism Factor 1
Factor Name Antidiabetic agents
Factor Description The hypoglycemic effect of antidiabetes may be reduced, leading to higher blood glucose, increased blood glucose fluctuations, and the possibility of hyperglycemic complications
      Mechanism Description
  • Antagonize the effect of Insulin human (zinc) when combined with Diltiazem 

Recommended Action
      Management While no special precautions appear to be necessary, patients may consider monitoring blood glucose more closely during the first few days or weeks of diltiazem therapy until glucose control is assured.

References
1 Sigusch H, Henschel L, Kraul H, Merkel U, Hoffmann A "Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects." Pharmazie 49 (1994): 675-9.[PMID: 7972311]
2 Christensen H, Asberg A, Holmboe AB, Berg KJ "Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers." Eur J Clin Pharmacol 58 (2002): 515-520.[PMID: 12451428]
3 Pershadsingh HA, Grant N, McDonald JM "Association of diltiazem therapy with increased insulin resistance in a patient with type I diabetes mellitus." JAMA 257 (1987): 930-1